Перейти к содержанию

NU Skin Enterprises, Inc. (NUS) stock: revenue, earnings & dividend

NU Skin Enterprises, Inc. (NUS, NYSE): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener NUS · NYSE Großhandel US-UT

Key figures

Fiscal year
2025
Revenue
1.49 bn $
Revenue growth
-14.3 %
Revenue growth 5y (p.a.)
-10.5 %
Net income
160 m $
Net margin
10.8 %
Operating margin
4.4 %
Earnings per share (diluted)
3.18 $
Dividend per share
–
Payout ratio
–
Consecutive dividend years
–
Consecutive dividend raises
–
Dividend growth 5y (p.a.)
–
Total assets
1.41 bn $
Equity
805 m $
Equity ratio
57.3 %
Return on equity
19.9 %
Cash
239 m $
Operating cash flow
80.3 m $
Free cash flow
46 m $
Shares outstanding
48,678,057

History

Revenue by fiscal year

2016 2.21 bn $
2017 2.28 bn $
2018 2.68 bn $
2019 2.42 bn $
2020 2.58 bn $
2021 2.7 bn $
2022 2.23 bn $
2023 1.97 bn $
2024 1.73 bn $
2025 1.49 bn $

Net income by fiscal year

2016 143 m $
2017 129 m $
2018 122 m $
2019 174 m $
2020 191 m $
2021 147 m $
2022 105 m $
2023 8.6 m $
2024 -146.59 m $
2025 160 m $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
20251.49 bn $160 m $3.18 $–80.3 m $
20241.73 bn $-146.59 m $-2.95 $–112 m $
20231.97 bn $8.6 m $0.17 $–119 m $
20222.23 bn $105 m $2.07 $–108 m $
20212.7 bn $147 m $2.86 $–142 m $
20202.58 bn $191 m $3.63 $–379 m $
20192.42 bn $174 m $3.10 $–178 m $
20182.68 bn $122 m $2.16 $–203 m $
20172.28 bn $129 m $2.36 $–303 m $
20162.21 bn $143 m $2.55 $–275 m $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)